ÂÜÀòÂÒÂ×

Rob is a partner at Hoxton Ventures. He represents the firm on the boards of Assetario, Boost Security, Bother, Deblock, FabricNano, Flair Impact, Formance, Kheiron Medical, LiliumX, Limbo Revolution, NoMagic, Ordercast, Pear Bio, Phagos, Preply and Spacelift, and previously was on the boards of Babylon Health (NYSE:BBLN), Campanja (acquired by 24/7 Media), Immunio (acquired by Trend Micro) and Vatic Health. He additionally works on Hoxton's interests in Ochre Bio, Optimoroute and Verb (Poetics).

Having spent most of his career in Silicon Valley, Rob came to London in 2008 to join the investments team at Fidelity Ventures, focusing on consumer internet and software-as-a-service sectors.

Prior to Fidelity, he was on the new business development team at Google and was previously a lead product manager for AdSense's front-end systems. While at Google, he also launched the AdWords pay-per-action (PPA) product and was actively involved in the acquisition of Feedburner in 2008.

Rob began his career in Intel's highly selective technical sales program where he worked to grow their entrepreneurial reseller channel in the Federal Government vertical and later in Latin America from Bogota and Miami Beach.

A dual US/UK national, he holds a BS in Computer Science from the University of Maryland and a Masters certificate in Management Science & Engineering from Stanford University.